OVERVIEW

The 2023 Conference will explore all aspects of pre-clinical, translational, and clinical research and care across NMD to support the development of better care and treatments for our community. Once again, MDA is excited to work with our planning committee, session chairs and speakers to deliver unparalleled content.

TARGET AUDIENCE

This activity is designed for an audience of nurses, pharmacists, physicians, physician assistants, and social workers.

LEARNING OBJECTIVES

Upon completion of the educational activity, participants should be able to:

• Discuss the challenges of the rapidly evolving neuromuscular treatment landscape, including administration of new therapeutics.
• Identify patients who are eligible for new treatments or clinical trials using genetic testing.
• Describe principles of the multidisciplinary care approach.

ACCREDITATION

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.